Autres langues Nanobiotix

Actions

NANO

FR0011341205

Temps réel Euronext Paris Autres places de cotation 13:10:33 07/06/2024			Varia. 5j.	Varia. 1 janv.
5,41 ^EUR	-3,57 %		-16,64 %	-18,52 %

03/06	Nanobiotix: résultats positifs pour le NBTXR3	AO
03/06	Fais-nous rêver, Christine

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Borsa di Italia: Facci sognare, Christine	03/06
Bolsa de Madrid: Haznos soñar, Christine	03/06
Nanobiotix : Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT Activated NBTXR3 Followed By anti PD 1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti PD 1 Therapy	02/06
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy	02/06
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy	02/06
Nanobiotix : Voting Results Shareholders Meeting of May 28 2024	29/05
Borsa di Italia: Nvidia sul punto di commettere un atto di lese-majeste contro Apple	29/05
Bolsa de Madrid: Nvidia al borde de cometer un acto de lesa majestad contra Apple	29/05
NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call	28/05
Nanobiotix S.A. Announces Presentation of New Data from Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology	28/05
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference	23/05
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference	23/05
Nanobiotix : mise à jour de la stratégie, le titre recule	22/05
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update	22/05
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update	22/05
Borsa di Italia: stasera si pubblica	22/05
Bolsa de Madrid: Ya-sabes-quién publica esta noche	22/05
Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship	21/05
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth	21/05
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth	21/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Nanobiotix

Actions

NANO

FR0011341205

Autres langues

Filtres